… Scientist Trident ProQR Therapeutics is a biotechnology company listed … the cell’s own editing machinery. In addition to Axiomer®, Trident TM is focused on developing an oligonucleotide-guided … premature termination codons are the primary target of the Trident technology. The R&D department is currently looking …